Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. Wang X, Hallen NR, Lee M, et al. Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. The Journal of allergy and clinical immunology. 2023. doi:10.1016/j.jaci.2023.01.030 Read more